Ignite Creation Date:
2024-05-06 @ 3:23 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02283190
Status:
COMPLETED
Last Update Posted:
2018-03-12
First Post:
2014-10-17
Brief Title:
1336GCC Study of Erwinaze for Treatment of Acute Myeloid Leukemia AML
Sponsor:
Ashkan Emadi
Organization:
University of Maryland Baltimore
Organization Data
Organization:
University of Maryland Baltimore
Class:
OTHER
Study ID:
1336GCC HP-00056335
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ashkan Emadi
Lead Sponsor Class:
OTHER
Responsible Party:
Ashkan Emadi
Responsible Party Title:
Sponsor-Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Maryland
Old Name:
None
Old Organization:
None